Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Using the LeiCNS-PK3.0 Physiologically-Based Pharmacokinetic Model to Predict Brain Extracellular Fluid Pharmacokinetics in Mice

    The unbound brain extracelullar fluid (brainECF) to plasma steady state partition coefficient, Kp,uu,BBB, values provide steady-state information on the extent of blood-brain barrier (BBB) transport equilibration...

    Mohammed A. A. Saleh, Berfin Gülave, Olivia Campagne in Pharmaceutical Research (2023)

  2. Article

    Professor Margareta Hammarlund-Udenaes - A Humble Scientist Sha** Modern Neuropharmacokinetics

    Irena Loryan, David E. Smith, Per Artursson, Douwe Breimer in Pharmaceutical Research (2022)

  3. Article

    Open Access

    Drug Distribution in Brain and Cerebrospinal Fluids in Relation to IC50 Values in Aging and Alzheimer’s Disease, Using the Physiologically Based LeiCNS-PK3.0 Model

    Very little knowledge exists on the impact of Alzheimer’s disease on the CNS target site pharmacokinetics (PK).

    Mohammed A. A. Saleh, Julia S. Bloemberg in Pharmaceutical Research (2022)

  4. Article

    Open Access

    The Extension of the LeiCNS-PK3.0 Model in Combination with the “Handshake” Approach to Understand Brain Tumor Pathophysiology

    Micrometastatic brain tumor cells, which cause recurrence of malignant brain tumors, are often protected by the intact blood–brain barrier (BBB). Therefore, it is essential to deliver effective drugs across no...

    Makoto Hirasawa, Mohammed A. A. Saleh, Elizabeth C. M. de Lange in Pharmaceutical Research (2022)

  5. Article

    Open Access

    Understanding Drug Delivery to the Brain Using Liposome-Based Strategies: Studies that Provide Mechanistic Insights Are Essential

    Brain drug delivery may be restricted by the blood-brain barrier (BBB), and enhancement by liposome-based drug delivery strategies has been investigated. As access to the human brain is limited, many studies h...

    Firda Juhairiyah, Elizabeth C. M. de Lange in The AAPS Journal (2021)

  6. Article

    Open Access

    Lumbar cerebrospinal fluid-to-brain extracellular fluid surrogacy is context-specific: insights from LeiCNS-PK3.0 simulations

    Predicting brain pharmacokinetics is critical for central nervous system (CNS) drug development yet difficult due to ethical restrictions of human brain sampling. CNS pharmacokinetic (PK) profiles are often al...

    Mohammed A. A. Saleh, Chi Fong Loo in Journal of Pharmacokinetics and Pharmacody… (2021)

  7. Article

    Open Access

    The 3D Brain Unit Network Model to Study Spatial Brain Drug Exposure under Healthy and Pathological Conditions

    We have developed a 3D brain unit network model to understand the spatial-temporal distribution of a drug within the brain under different (normal and disease) conditions. Our main aim is to study the impact o...

    Esmée Vendel, Vivi Rottschäfer, Elizabeth C.M. de Lange in Pharmaceutical Research (2020)

  8. No Access

    Article

    Mind the Gaps: Ontogeny of Human Brain P-gp and Its Impact on Drug Toxicity

    Available data on human brain P-glycoprotein ontogeny during infancy and childhood are limited. This review discusses the current body of data relating to maturation of human brain P-glycoprotein including tra...

    Jean-Marie Nicolas, Elizabeth C. M. de Lange in The AAPS Journal (2019)

  9. Article

    Open Access

    Correction to: Modelling the delay between pharmacokinetics and EEG effects of morphine in rats: binding kinetic versus effect compartment models

    The original version of this article was published open access. Unfortunately, due to a technical issue, the copyright holder name in the online version (HTML and XML) is incorrectly published as “Springer Sci...

    Wilhelmus E. A. de Witte, Vivi Rottschäfer in Journal of Pharmacokinetics and Pharmacody… (2018)

  10. Article

    Open Access

    Modelling the delay between pharmacokinetics and EEG effects of morphine in rats: binding kinetic versus effect compartment models

    Drug–target binding kinetics (as determined by association and dissociation rate constants, kon and koff) can be an important determinant of the kinetics of drug action. However, the effect compartment model is u...

    Wilhelmus E. A. de Witte, Vivi Rottschäfer in Journal of Pharmacokinetics and Pharmacody… (2018)

  11. Article

    Open Access

    Target and Tissue Selectivity Prediction by Integrated Mechanistic Pharmacokinetic-Target Binding and Quantitative Structure Activity Modeling

    Selectivity is an important attribute of effective and safe drugs, and prediction of in vivo target and tissue selectivity would likely improve drug development success rates. However, a lack of understanding of ...

    Anna H. C. Vlot, Wilhelmus E. A. de Witte, Meindert Danhof in The AAPS Journal (2017)

  12. Article

    Erratum to: Microdialysis: the Key to Physiologically Based Model Prediction of Human CNS Target Site Concentrations

    Yumi Yamamoto, Meindert Danhof, Elizabeth C. M. de Lange in The AAPS Journal (2017)

  13. Article

    Open Access

    Microdialysis: the Key to Physiologically Based Model Prediction of Human CNS Target Site Concentrations

    Despite the enormous research efforts that have been put into the development of central nervous system (CNS) drugs, the success rate in this area is still disappointing. To increase the successful rate in the...

    Yumi Yamamoto, Meindert Danhof, Elizabeth C. M. de Lange in The AAPS Journal (2017)

  14. Article

    Open Access

    A Generic Multi-Compartmental CNS Distribution Model Structure for 9 Drugs Allows Prediction of Human Brain Target Site Concentrations

    Predicting target site drug concentration in the brain is of key importance for the successful development of drugs acting on the central nervous system. We propose a generic mathematical model to describe the...

    Yumi Yamamoto, Pyry A. Välitalo, Dirk-Jan van den Berg in Pharmaceutical Research (2017)

  15. Article

    Open Access

    Emerging Insights for Translational Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Studies: Towards Prediction of Nose-to-Brain Transport in Humans

    To investigate the potential added value of intranasal drug administration, preclinical studies to date have typically used the area under the curve (AUC) in brain tissue or cerebrospinal fluid (CSF) compared ...

    Mitchel J. R. Ruigrok, Elizabeth C. M. de Lange in The AAPS Journal (2015)

  16. Article

    Open Access

    Diurnal Variation in P-glycoprotein-Mediated Transport and Cerebrospinal Fluid Turnover in the Brain

    Nearly all bodily processes exhibit circadian rhythmicity. As a consequence, the pharmacokinetic and pharmacodynamic properties of a drug may also vary with time of day. The objective of this study was to inve...

    Laura Kervezee, Robin Hartman, Dirk-Jan van den Berg, Shinji Shimizu in The AAPS Journal (2014)

  17. Article

    Open Access

    Utility of CSF in translational neuroscience

    Human cerebrospinal fluid (CSF) sampling is of high value as the only general applicable methodology to obtain information on free drug concentrations in individual human brain. As the ultimate interest is in ...

    Elizabeth C. M. de Lange in Journal of Pharmacokinetics and Pharmacodynamics (2013)

  18. Article

    Open Access

    The impact of P-gp functionality on non-steady state relationships between CSF and brain extracellular fluid

    In the development of central nervous system (CNS)-targeted drugs, the prediction of human CNS target exposure is a big challenge. Cerebrospinal fluid (CSF) concentrations have often been suggested as a ‘good ...

    Joost Westerhout, Jean Smeets in Journal of Pharmacokinetics and Pharmacody… (2013)

  19. No Access

    Article

    Mechanism-based PK–PD model for the prolactin biological system response following an acute dopamine inhibition challenge: quantitative extrapolation to humans

    The aim of this investigation was to develop a mechanism-based pharmacokinetic–pharmacodynamic (PK–PD) model for the biological system prolactin response following a dopamine inhibition challenge using remoxip...

    Jasper Stevens, Bart A. Ploeger in Journal of Pharmacokinetics and Pharmacody… (2012)

  20. Article

    Open Access

    Physiologically Based Pharmacokinetic Modeling to Investigate Regional Brain Distribution Kinetics in Rats

    One of the major challenges in the development of central nervous system (CNS)-targeted drugs is predicting CNS exposure in human from preclinical data. In this study, we present a methodology to investigate b...

    Joost Westerhout, Bart Ploeger, Jean Smeets, Meindert Danhof in The AAPS Journal (2012)

previous disabled Page of 2